Starling Oncology, Inc. Derivative Liability
Starling Oncology, Inc. (STLN) had Derivative Liability of $12.65 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2022-11-09
- 2022-09-30: Derivative Liability $12.65M.
| Period end | Derivative Liability |
|---|---|
| 2022-09-30 | $12.65M 10-Q · filed 2022-11-09 |